Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, UCSD, 9500 Gilman Dr. La Jolla, CA 92093-0204, USA.
Chemistry. 2010 Nov 8;16(42):12512-25. doi: 10.1002/chem.201001279.
The ocean contains a host of macroscopic life in a great microbial soup. Unlike the terrestrial environment, an aqueous environment provides perpetual propinquity and blurs spatial distinctions. Marine organisms are under a persistent threat of infection by resident pathogenic microbes including bacteria, and in response they have engineered complex organic compounds with antibacterial activity from a diverse set of biological precursors. The diluting effect of the ocean drives the construction of potent molecules that are stable to harsh salty conditions. Members of each class of metabolite-ribosomal and non-ribosomal peptides, alkaloids, polyketides, and terpenes-have been shown to exhibit antibacterial activity. The sophistication and diversity of these metabolites points to the ingenuity and flexibility of biosynthetic processes in Nature. Compared with their terrestrial counterparts, antibacterial marine natural products have received much less attention. Thus, a concerted effort to discover new antibacterials from marine sources has the potential to contribute significantly to the treatment of the ever increasing drug-resistant infectious diseases.
海洋中充满了大量的微生物,其中也存在许多宏观生物。与陆地环境不同,水的环境提供了持续的接近度,并模糊了空间上的区别。海洋生物持续受到驻留的致病性微生物(包括细菌)的感染威胁,因此它们利用多种多样的生物前体设计出了具有抗菌活性的复杂有机化合物。海洋的稀释作用促使构建出在恶劣的盐条件下稳定的有效分子。每一类代谢物——核糖体和非核糖体肽、生物碱、聚酮和萜类——都表现出抗菌活性。这些代谢物的复杂性和多样性表明了自然界生物合成过程的巧妙性和灵活性。与陆地同类物相比,抗菌海洋天然产物受到的关注要少得多。因此,从海洋来源发现新的抗菌药物的协同努力有可能对治疗日益增加的耐药性传染病做出重大贡献。